Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications

E-ISSN： 1873-4286|22|16|2323-2332

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.16, 2016-05, pp. : 2323-2332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS

Current Cancer Drug Targets, Vol. 6, Iss. 6, 2006-09 ,pp. : 553-563

Bentham Science Publishers

Access to resources Recommend Favorite

Current Status of Allogeneic Hematopoietic Cell Transplantation for MDS

Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. : 3215-3221

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Liver Diseases on Drug-metabolizing Enzymes: Implications for Drug Fate Alterations and Nano-therapeutic Openings

Current Medicinal Chemistry, Vol. 21, Iss. 22, 2014-07 ,pp. : 2522-2541

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Hypermethylation of Myeloid Cells, A Novel Therapeutic Target in MDS and AML

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-01 ,pp. : 315-321

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Hematopoietic Cells to Therapeutic Angiogenesis

Current Pharmaceutical Design, Vol. 12, Iss. 5, 2006-02 ,pp. : 557-563

Bentham Science Publishers

Access to resources Recommend Favorite